|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,455.00 JPY | +2.09% |
|
-6.18% | -18.73% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: May | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Drug Stores and Pharmacies | ||||||||||
Retail Business of Pharmaceuticals and Cosmetics | 726B | 755B | 828B | 965B | 1,011B | |||||
Total Assets | 341B | 363B | 421B | 477B | 525B | |||||
Interest Expense | -60M | -52M | -51M | -99M | -254M | |||||
Income Tax Expense | 11.44B | 9.89B | 8.98B | 9.26B | 11.39B | |||||
CAPEX | -26.06B | -43.5B | -46.64B | -55.81B | -53.33B | |||||
EBT | 38.6B | 33.05B | 32.77B | 33.72B | 42.37B | |||||
Gross Profit | 145B | 151B | 169B | 188B | 213B | |||||
D&A | 13.78B | 15.11B | 17.37B | 19.92B | 22.23B | |||||
Operating Income | 33.15B | 29.8B | 30.13B | 31.5B | 40.4B | |||||
Net Income | 27.16B | 23.16B | 23.8B | 24.45B | 30.98B |
Geographical Revenue Distribution History
| Fiscal Period: May | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Japan | 726B | 755B | 828B | 965B | 1,011B | |||||
Total Assets | 341B | 363B | 421B | 477B | 525B | |||||
Interest Expense | -60M | -52M | -51M | -99M | -254M | |||||
Income Tax Expense | 11.44B | 9.89B | 8.98B | 9.26B | 11.39B | |||||
D&A | 13.78B | 15.11B | 17.37B | 19.92B | 22.23B | |||||
CAPEX | -26.06B | -43.5B | -46.64B | -55.81B | -53.33B | |||||
Gross Profit | 145B | 151B | 169B | 188B | 213B | |||||
Net Income | 27.16B | 23.16B | 23.8B | 24.45B | 30.98B | |||||
EBT | 38.6B | 33.05B | 32.77B | 33.72B | 42.37B | |||||
Operating Income | 33.15B | 29.8B | 30.13B | 31.5B | 40.4B |
- Stock Market
- Stocks
- 3349 Stock
- Financials COSMOS Pharmaceutical Corporation
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
